Gufic Biosciences
GUFICBIO · Pharma > Pharmaceuticals & Drugs · Chairman: Jayesh P Choksi · MD: Jayesh P Choksi · Listing date: Oct. 20, 2004 · Employees: 1247 · Mumbai · http://gufic.com

Stock Price vs Company Growth
1d
7.1%
1w
12.5%
1m
17.3%
3m
18.8%
6m
18.0%
1y
8.7%
5y
39.5%
10y
37.4%
all
20.9%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec10Jun14Dec17Jun21Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

336 7.1%
334
498
Company Overview

Sales
810 Cr
Growth: 4.0%
Profit after Tax
82 Cr
Growth: -3.5%
Small Cap
3,369 Cr
P/E: 41.1x
Industry P/E: 29.4x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 810
Growth 4.0%
EBITDA 17.6%
P/S 4.2x
Dividend 0.0%
P/E 41.1x
Book Value ₹ 1
PEG Ratio 10.2x
ROE 817.5%
P/B N/A
Shareholding Pattern

Institutions
Sbi Healthcare Opportunities Fund
2.61 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Jun21Sep21Mar22Sep22Dec22
Promoters
Mr. Jayesh P. Choksi
25.95 %
Zircon Teconica Private Limited (Formely Known As Zircon Finance & Leasing Private Limited)
21.17 %
Gufic Private Limited
10.51 %
Mr. Pranav J. Choksi
7.5 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Jun21Sep21Mar22Sep22Dec22
Others
Vipula Jayesh Choksi
10.35 %
Jagdish N Master
1.65 %
Iepf
0.21 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Jun21Sep21Mar22Sep22Dec22
Increase    Decrease    No change
Company Profile Detailed

The company is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.Products of the companyPharmaceuticalHerbalAPI / Bulk DrugsPersonal careInternationalHistory and milestonePast InitiativesFirst Indian to produce Doxycycline Inj.First Indian company to make Liquid Oxytetracycline Inj.
Investors (46)
Followers (7)